Role of dietary beta-glucans in the prevention of the metabolic syndrome.
(2012) In Nutrition Reviews 70(8). p.444-458- Abstract
- The present review examines the evidence regarding the effect of β-glucan on variables linked to the metabolic syndrome (MetS), including appetite control, glucose control, hypertension, and gut microbiota composition. Appetite control can indirectly influence MetS by inducing a decreased energy intake, and promising results for a β-glucan intake to decrease appetite have been found using gut hormone responses and subjective appetite indicators. Beta-glucan also improves the glycemic index of meals and beneficially influences glucose metabolism in patients with type 2 diabetes or MetS, as well as in healthy subjects. Furthermore, a blood-pressure-lowering effect of β-glucan in hypertensive subjects seems fairly well substantiated. The gut... (More)
- The present review examines the evidence regarding the effect of β-glucan on variables linked to the metabolic syndrome (MetS), including appetite control, glucose control, hypertension, and gut microbiota composition. Appetite control can indirectly influence MetS by inducing a decreased energy intake, and promising results for a β-glucan intake to decrease appetite have been found using gut hormone responses and subjective appetite indicators. Beta-glucan also improves the glycemic index of meals and beneficially influences glucose metabolism in patients with type 2 diabetes or MetS, as well as in healthy subjects. Furthermore, a blood-pressure-lowering effect of β-glucan in hypertensive subjects seems fairly well substantiated. The gut microbiota composition might be an interesting target to prevent MetS, and preliminary results indicate the prebiotic potential of β-glucan. The evidence that β-glucan influences appetite control and gut microbiota in a positive way is still insufficient or difficult to interpret, and additional studies are needed in this field. Still, much evidence indicates that increased β-glucan intake could prevent MetS. Such evidence should encourage increased efforts toward the development of β-glucan-containing functional foods and promote the intake of β-glucan-rich foods, with the aim of reducing healthcare costs and disease prevalence. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/2966540
- author
- Cloetens, Lieselotte LU ; Ulmius, Matilda LU ; Johansson Persson, Anna LU ; Åkesson, Björn LU and Önning, Gunilla LU
- organization
- publishing date
- 2012
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Nutrition Reviews
- volume
- 70
- issue
- 8
- pages
- 444 - 458
- publisher
- Oxford University Press
- external identifiers
-
- wos:000306894900004
- pmid:22835138
- scopus:84864335174
- pmid:22835138
- ISSN
- 1753-4887
- DOI
- 10.1111/j.1753-4887.2012.00494.x
- language
- English
- LU publication?
- yes
- id
- b76b3ae4-f98b-4eb8-960e-83bac13e9580 (old id 2966540)
- date added to LUP
- 2016-04-01 14:44:55
- date last changed
- 2022-03-29 22:41:38
@article{b76b3ae4-f98b-4eb8-960e-83bac13e9580,
abstract = {{The present review examines the evidence regarding the effect of β-glucan on variables linked to the metabolic syndrome (MetS), including appetite control, glucose control, hypertension, and gut microbiota composition. Appetite control can indirectly influence MetS by inducing a decreased energy intake, and promising results for a β-glucan intake to decrease appetite have been found using gut hormone responses and subjective appetite indicators. Beta-glucan also improves the glycemic index of meals and beneficially influences glucose metabolism in patients with type 2 diabetes or MetS, as well as in healthy subjects. Furthermore, a blood-pressure-lowering effect of β-glucan in hypertensive subjects seems fairly well substantiated. The gut microbiota composition might be an interesting target to prevent MetS, and preliminary results indicate the prebiotic potential of β-glucan. The evidence that β-glucan influences appetite control and gut microbiota in a positive way is still insufficient or difficult to interpret, and additional studies are needed in this field. Still, much evidence indicates that increased β-glucan intake could prevent MetS. Such evidence should encourage increased efforts toward the development of β-glucan-containing functional foods and promote the intake of β-glucan-rich foods, with the aim of reducing healthcare costs and disease prevalence.}},
author = {{Cloetens, Lieselotte and Ulmius, Matilda and Johansson Persson, Anna and Åkesson, Björn and Önning, Gunilla}},
issn = {{1753-4887}},
language = {{eng}},
number = {{8}},
pages = {{444--458}},
publisher = {{Oxford University Press}},
series = {{Nutrition Reviews}},
title = {{Role of dietary beta-glucans in the prevention of the metabolic syndrome.}},
url = {{http://dx.doi.org/10.1111/j.1753-4887.2012.00494.x}},
doi = {{10.1111/j.1753-4887.2012.00494.x}},
volume = {{70}},
year = {{2012}},
}